Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Brazil Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20141
20151
20173
20192
20201
20215
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed5
Terminated5
Recruiting4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital de Clinicas de Porto Alegre2
Universidade Federal do Rio de Janeiro2
University of Sao Paulo General Hospital2
89bio, Inc.1
Akero Therapeutics, Inc1
AstraZeneca1
Bristol-Myers Squibb1
Camila Ribeiro de Avelar1
Eli Lilly and Company1
Federal University of Health Science of Porto Alegre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease23
Fatty Liver6
Liver Diseases4
Liver Cirrhosis3
Fibrosis2
Cardiovascular Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Digestive System Diseases1
Epilepsy1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.